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Orthosiphonstamineus commonly known as kumis kucing has
been used traditionally for rheumatoid, gout, renal calculus,
hypertension, diabetes, etc. [1]. It is often used in combina-
tion with synthetic hypertensive drugs like irbesartan. However,
both effectiveness combination herbal medicine with modern
pharmaceuticals, and the possible adverse effects from herb–
drug interactions remain to be verified.
This study investigated effect of O. stamineus extract to phar-
macokinetics of irbesartan co-administration in Sprague Dawley
rats. After O. stamineus extract pretreatment (500 mg/kg BW)
for 6 days orally, on the seventh day rats were administered
irbesartan (40 mg/kg BW) orally, then the blood sample were
collected into heparinized tube via sinus orbitalis at 0, 0.5, 1,
1.5, 2, 2.5, 3, 4, 8, 12, 24 and 36 hours after drug administra-
tion, then centrifuged at 10,000 rpm for 10 minutes to separate
out plasma. The rat plasma was extracted by protein precipi-
tation with acetonitril and analyzed by liquid chromatography
tandem mass spectrometry, with an electrospray ionization (ESI)
source at positive ion mode in the multiple reaction monitor-
ing (MRM), was detected at m/z 429.1 > 205.9 (for irbesartan),
m/z 373 > 342.9 (for sinensetin) and m/z 423.05 > 404.9 (for
losartan as internal standard). The plasma concentration
irbesartan in the group combination of irbesartan and extract
of O. stamineus was 4843.25 ng/mL and half time was 32.07
hours, higher and prolonged than the group irbesartan alone
(2426.20 ng/mL and 23.82 hours). The pharmacokinetic pro-
files are in Fig. 1. According to the in vitro study it was shown
that the extract of O. stamineus has potent inhibitory activity
against CYP2C9 [2], so the herb–drug interaction mechanism
may be due to the inhibitor of CYP2C9, because irbesartan is
also metabolized by CYP2C9. The results showed that con-
comitant use of irbesartan and extract of Orthosiphon stamineus
increased the plasma level (Cmax) and prolonged the half life
(t1/2) of irbesartan.
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Fig. 1 – The pharmacokinetic profile of irbesartan alone
(n = 5) and irbesartan + extract of O. stamineus (n = 5).
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